Reactions

Reactions

Reactions

When science hits the headlines, we seek the views of expert sources who assess the news rigorously and quickly, according to the available evidence.

Reaction: Study warns of lack of literacy about deepfakes during wartime

A research project has analysed the Twitter discourse related to deepfakes in the context of the Russia-Ukraine war in 2022, studying almost 5,000 tweets related to these videos. Deepfakes are synthetic media that mix an original video with content generated by artificial intelligence, often with the aim of mimicking a person. The research, published in PLoS ONE, looks at the lack of literacy about deepfakes and the scepticism and misinformation that can arise when real media is mistakenly identified as fake. The authors warn that efforts to raise public awareness of this phenomenon can undermine trust in other legitimate media, that can also be seen as suspect.

0

Reaction: An artificial intelligence method shows human-like generalization ability

In a work published in the journal Nature, two researchers from New York University (USA) and Pompeu Fabra University in Barcelona claim to have demonstrated that an artificial neural network can have systematic generalization capabilities similar to human ones, that is, to learn new concepts and combine them with existing ones. This statement calls into question the 35-year-old idea that neural networks are not viable models of the human mind.

0

Reaction: Study finds tai chi may slow progression of Parkinson's disease

Research by researchers in Shanghai, China, suggests that continued practice of tai chi can slow the progression of Parkinson's disease symptoms and delay the need for increased doses of medication. The study compared 143 people who underwent tai chi training with 187 non-trainees who served as a control group. The results are published in the Journal of Neurology Neurosurgery & Psychiatry.

0

Reaction: Artificial protein designed to degrade microplastics

Based on a defense protein of the strawberry anemone, researchers from the Barcelona Supercomputing Center, CSIC and the Complutense University of Madrid have designed, through artificial intelligence and the use of supercomputers, an artificial protein capable of degrading PET micro and nanoplastics, such as those used in bottles. According to the authors, its efficiency is between 5 and 10 times higher than that of the proteins currently used and it works at room temperature. The results are published in the journal Nature Catalysis.

0

Reaction: Zoonoses from domestic animals pose an underestimated but very real threat, review finds

A review examines the role of domestic and semi-domestic animals, such as cats, in the emergence of potential zoonoses due to their close contact with humans. The paper, published in the journal Science Translational Medicine, concludes that companion animal health risks will become increasingly problematic with climate change and rapid urbanisation.

0

Reaction to study showing avian influenza epicentre has shifted from Asia to Africa and Europe

An international group of scientists has studied epidemiological data since 2005 and more than 10,000 viral genomes to conclude that the epicentre of H5 avian influenza has shifted from Asia to parts of Africa and Europe. New lineages have emerged from these regions between 2020 and 2022, which evolved by genetic reassortment with low pathogenic viral variants as they spread. According to the authors, who publish their findings in the journal Nature, the increasing persistence of avian influenza in wild bird populations may be driving the evolution and spread of new strains.

0

Reactions: study warns of low treatment rates for mental disorders in children and adolescents

A meta-analysis, pooling the results of 40 previous studies - involving more than 310,000 children and adolescents in total - concludes that treatment rates for mental disorders in these age groups are "generally low, especially for depression and anxiety". The research, published in JAMA Network Open, shows that the treatment rate for any mental disorder is 38%, ranging from 31% for anxiety, 36% for depression, 49% for conduct disorders and 58% for attention deficit hyperactivity disorder (ADHD).

0

Reaction: spermidine supplementation improves fertility in aged female mice

Spermidine is a naturally occurring compound that has been linked to increased longevity in some organisms. New research shows that supplementation with this compound improves oocyte quality and fertility in older female mice. If its action and safety in humans is confirmed, the authors argue that it could serve as a therapeutic strategy to "improve the reproductive outcome of older women, either through natural pregnancy or assisted reproductive technologies". The results are published in the journal Nature Aging.
 

0

Reactions to the publication of the world's largest high-resolution atlas of brain cells

The Science group of journals publishes several parts of a high-resolution atlas of human brain cells, the largest 'map' of its kind to date. It is a series of papers from an international mega-project, the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative - Cell Census Network (BICCN), launched in 2017 to study brain cell types and their functions in humans, non-human primates and rodents. The data "will now allow researchers to address fundamental scientific questions about the human brain and its genetic organisation," states the introduction to the journal's special issue.

0

Reactions: Cell therapy 'teaches' immune system to tolerate liver transplants, phase 1 trial shows

Currently, when an organ transplant is performed, the patient has to take immunosuppressive drugs to prevent his or her system from rejecting the new organ. These drugs must be taken for life and have numerous side effects. In a phase 1 clinical trial, researchers gave patients receiving a liver transplant regulatory dendritic cells derived from the original donor, with the hypothesis that these cells could 'teach' the recipient's immune system to tolerate the new organ. The research, published in Science Translational Medicine, suggests that this treatment could reduce or even eliminate the need for long-term use of immunosuppressants.

0